Protocol to Ease Acute Cephalalgia in Emergency-department (PEACE)

October 11, 2016 updated by: University Hospital, Grenoble

Therapeutic Management of Acute Cephalalgia Before and After Use of a Therapeutic Protocol in Emergency Department

The purpose of this study is to determine if the use of a therapeutic and global protocol to relieve cephalalgia is helpful in the emergency department of Grenoble University Hospital.

Study Overview

Status

Completed

Conditions

Detailed Description

Cephalalgia is a very common symptom that justifies daily appointment in emergency department.

Analgesic support, and especially use of oxygen and care of associated symptoms as nausea, photophobia or phonophobia, is very dependent on the physician.

The aim of this study is to evaluate the impact of a global analgesic protocol of cephalalgia in emergency department.

The investigators included 200 patients aged of 18 up to 55 years old coming in emergency department for headache. Pain (Visual analogic scale), nausea, photo or phonophobia are recorded each 15 minutes by the patient by using a self-assessment questionnaire. The final diagnosis is recorded by the physician in charge of patient, using International Headache Society criteria.

First 100 patients(group 1) receive usual care.

For the last 100 patients (group 2), physician in charge of patients are incited to use a formal protocol that include: putting the patient in a quiet spot, laying down on a stretcher, providing sound proof helmet and light blocking google, administering oxygen therapy 15 l/min during 15 min, and administering etiological headache adapted medication following learned society guidelines.

Comparison of the data of this 2 groups shall help us to see if the investigators actual analgesic support of cephalalgia is efficient, and if it can be improved by this global analgesic protocol.

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Isere
      • Grenoble, Isere, France, 38700
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Complain about cephalalgia
  • Age 28 to 55 years.

Exclusion Criteria:

  • Fever > 38,0 °C
  • History of breath disease, long term use of oxygen therapy, chronic obstructive pulmonary disease, dyspnea
  • History of cranial traumatism, heart attack, cerebrovascular accident <3 month
  • Inability to read or understand french.
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care
First arm : Passive recording head pain, linked symptoms, treatment used and diagnosis.
Experimental: After protocol recommendation care
Recording head pain, linked symptoms, treatment used and diagnosis after intervention that is recommendation to use global headache treatment protocol

The global treatment protocol is :

  1. Put the patient in a quiet spot, ideally an individual room. Avoid waiting in the corridor
  2. Lay down the patient on the stretcher. Avoid waiting on a seat or a chair.
  3. Provide a sound-proof helmet to the patient.
  4. Provide a light-blocking google to the patient.
  5. If judged necessary by the physician in charge of the patient, administer oxygen therapy, 15 liter per minute, during 15 minutes.
  6. If judged necessary by the physician in charge of the patient, administer analgesic treatment adapted to the etiology of the cephalalgia as described :

Migraine : acetylsalicilyc acid + metoclopramide or nonsteroidal anti inflammatory or paracetamol or triptan.

Tension headache : nonsteroidal anti inflammatory or paracetamol. Avoid methylmorphine or tramadol if possible.

Cluster headache : Intravenous or nasal spray sumatriptan and oxygen therapy.

Other etiology : Treatment left at the discretion of the physician in charge of the patient.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical improvement
Time Frame: 1 hour after treatment
"Clinical improvement" is defined as "Reduction of at least 50% of quantified pain 1 hour after treatment Comparison of proportion of "clinical improvement" between the 2 groups.
1 hour after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain score on the visual analog scale
Time Frame: 1 hour after treatment

Measure of amount of pain by recording quantified pain evaluation each 15 minutes. Analysis by ANOVA (Analysis of Variance).

Comparison between the 2 groups.

1 hour after treatment
Pain depending on the kind of cephalalgia
Time Frame: 1 hour after treatment
Research of interaction between the occurrence of the "clinical improvement" and the cephalalgia diagnosis (Migraine, tensive headache, cluster headache, secondary headache...).
1 hour after treatment
Impact of different kind of analgesic therapeutic
Time Frame: 1 hour after treatment
Research of interaction between the occurrence of "clinical improvement" and the use of specific therapeutic strategy ( Restful position, calm environment, wearing opaque glasses, soundproof headset, oxygen therapy, other medication, ...)
1 hour after treatment
Length of the hospitalization in emergency department
Time Frame: Duration of hospitalisation in emergency department stay, an expected average of 6 hours
Evaluation of the length of the hospitalization in emergency department. Comparison between the 2 groups
Duration of hospitalisation in emergency department stay, an expected average of 6 hours
Time required before medication
Time Frame: Time of administration of first medication, an expected average of 30 minutes

Evaluation of the length of time before first administration of analgesic treatment.

Comparison between the 2 groups

Time of administration of first medication, an expected average of 30 minutes
Hospitalisation requirement
Time Frame: Exit of emergency department, an expected average of 6 hours

Evaluation of hospitalisation requirement at the exit of emergency department.

Comparison between the 2 groups

Exit of emergency department, an expected average of 6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gabriel Mirebeau, Resident, University Hospital, Grenoble

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

September 1, 2015

Study Registration Dates

First Submitted

August 7, 2014

First Submitted That Met QC Criteria

September 8, 2014

First Posted (Estimate)

September 10, 2014

Study Record Updates

Last Update Posted (Estimate)

October 12, 2016

Last Update Submitted That Met QC Criteria

October 11, 2016

Last Verified

October 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cephalalgia

Clinical Trials on Recommendation to use global headache treatment protocol

Subscribe